Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation

Human Reproduction

Volumn 15, Issue 10, 2000, Pages 2093-2097

  Zegers Hochschild, F ^a   Balmaceda, J P ^a   Fabres, C ^a   Alam, V ^a   Mackenna, A ^a   Fernandez E ^a   Pacheco, I M ^a   Sepulveda M S ^a   Chen, S ^b   Borrero, C ^c   Borges, E ^d  

^a CLÍNICA LAS CONDES   (Chile)

^b GRÜNENTHAL GMBH   (Germany)

^c Unidad de Fertilidad del Country   (Colombia)

^d FERTILITY Centro de Fertilización Asistida   (Brazil)

Author keywords

IVF; Oocyte donation; Progesterone supplementation; Vaginal ring

Indexed keywords

ESTRADIOL; POLYSILOXANE; PROGESTERONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG IMPLANTATION; DRUG RELEASE; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GONADAL AGENESIS; HORMONE SUBSTITUTION; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OOCYTE DONATION; PREGNANCY RATE; PROGESTERONE RELEASE; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; VAGINA RING;

EID: 0033776897     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.10.2093     Document Type: Article

References (18)

1. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites
2. New hypotheses. Transvaginal progesterone: Evidence for a new functional 'portal system' flowing from the vagina to the uterus
3. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins
4. Transvaginal administration of progesterone
5. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: A comparative study between vaginal and oral administration
6. Experience with a novel vaginal progesterone preparation in a donor oocyte program
7. Vaginal ring steroid releasing systems
8. Oral versus intramuscular progesterone for in vitro fertilization: A prospective randomized study
9. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in chilean nursing women
10. Bioavailability of oral micronized progesterone
11. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: A comparative study
12. Intramuscular versus vaginal progesterone in assisted reproduction: A comparative study
13. Luteal support after in vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone
14. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement
15. The role of luteal phase support in infertility treatment: A meta-analysis of randomized trials
16. The normal menstrual cycle
17. Luteal estrogen is not required for the establishment of pregnancy in the human
18. Endometrial histology and progesterone concentration in women with ovarian failure supplemented with a progesterone vaginal ring. Report on six pregnancy cycles after oocyte donation